Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) stock news · P/E 40, rev $3.02B
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
This AMRX news page leads with what Amneal Pharmaceuticals, Inc. Class A Common Stock filed — not a scraped headline mill.
No cached 8-K sentence for AMRX yet. We will not pad this page with generic market recap.
Latest reported AMRX revenue for 2025-12-31 was $3.02B. Net income was $72.1M. Revenue was up 8.0% from 2024-12-31 to 2025-12-31. AMRX currently screens at market cap $5.19B and trailing P/E 40.0.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the AMRX stock page; for the tape open the quote page.
AMRX stock news FAQ
What are AMRX's latest revenue and net income?
Latest cached Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) revenue for Dec 31, 2025 was $3.02B. Net income was $72.1M. Statements: https://lician.com/financials/amrx
How did AMRX revenue change from the prior cached period?
Cached Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) revenue was up 8.0% from $2.79B (Dec 31, 2024) to $3.02B (Dec 31, 2025). Statements: https://lician.com/financials/amrx
What is AMRX's P/E ratio?
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) trailing P/E is 40.0 on the latest cached fundamentals snapshot.
What is AMRX's market cap?
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) market cap is $5.19B on the latest cached fundamentals snapshot.
What kind of company is AMRX?
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Where is AMRX stock news listed?
Cached stock news for Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) is listed at https://lician.com/news/amrx. Filings: https://lician.com/sec/amrx
Not investment advice.